Figures computed from official regulatory filings — methodology.
Statistical track record
FreeWin rates and median returns are available with a free account (5 insiders/month).
Create a free accountThis page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
| Company | Type | Value · USD | |
|---|---|---|---|
| Other | $70.8K | SEC | |
| ExerciseD | $0 | SEC | |
| Exercise | $70.8K | SEC | |
| ExerciseD | $0 | SEC | |
| Exercise | $7.3K | SEC | |
| ExerciseD | $0 | SEC | |
| Exercise | $29.2K | SEC | |
| Buy | $7.5K | SEC | |
| AwardD | $0 | SEC | |
| Buy | $7.2K | SEC | |
| Buy | $7K | SEC | |
| AwardD | $0 | SEC | |
| Buy | $10.9K | SEC | |
| AwardD | $0 | SEC | |
| Buy | $5.5K | SEC | |
| Buy | $19.2K | SEC | |
| ExerciseD | $36.5K | SEC | |
| Buy | $11.3K | SEC | |
| Buy | $10K | SEC | |
| Buy | $3.3K | SEC | |
| Buy | $10K | SEC | |
| Buy | $8K | SEC |